Intrathecal CGRP8-37-induced bilateral increase in hindpaw withdrawal latency in rats with unilateral inflammation

British Journal of Pharmacology

Volumn 117, Issue 1, 1996, Pages 43-50

  Yu, Long Chuan ^a,d   Hansson, Per ^b   Brodda Jansen, Gunilla ^a   Theodorsson, Elvar ^c   Lundeberg, Thomas ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Academic Hospital   (Sweden)

^d PEKING UNIVERSITY   (China)

Author keywords

Bilateral effects; Calcitonin gene related peptide (CGRP); Carrageenan; CGRP like immunoreactivity; CGRP8 37; Hindpaw withdrawal latency (HWL); Hindpaw withdrawal threshold (HWT); Naloxone; Nociceptive test; Unilateral experimental inflammation

Indexed keywords

CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE (8 37); CALCITONIN GENE-RELATED PEPTIDE (8-37); CARRAGEENAN; NALOXONE; NARCOTIC ANTAGONIST; PEPTIDE FRAGMENT; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; OPIATE; RECEPTOR BLOCKING AGENT;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG INTERACTION; HINDLIMB; INFLAMMATION; INTRASPINAL DRUG ADMINISTRATION; MALE; METABOLISM; PAIN ASSESSMENT; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; ANIMAL EXPERIMENT; CEREBROSPINAL FLUID; CONTROLLED STUDY; IMMUNOREACTIVITY; MONONEUROPATHY; NOCICEPTION; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; THERMAL STIMULATION; WITHDRAWAL REFLEX;

ANIMALS; CALCITONIN; CALCITONIN GENE-RELATED PEPTIDE; CARRAGEENAN; DRUG INTERACTIONS; HINDLIMB; INFLAMMATION; INJECTIONS, SPINAL; MALE; NALOXONE; NARCOTIC ANTAGONISTS; PAIN MEASUREMENT; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0029671010     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15152.x     Document Type: Article

References (50)

1. BIELLA, G., PANARA, C., PECILE, A. & SATGIU, M.L. (1991). Facilitatory role of calcitonin gene-related peptide (CGRP) on excitation induced by substance P and noxious stimuli in rat spinal dorsal horn neurones: An iontophoretic study in vivo. Brain Res., 559, 352-356.
2. BILEVICIUTE, I., LUNDEBERG, T., EKBLOM, A. & THEODORSSON, E. (1993). Bilateral changes of substance P-, neurokinin A-, calcitonin gene-related peptide-and neuropeptide Y-like immunoreactivity in rat knee joint synovial fluid during acute monoarthritis. Neurosci. Lett., 153, 37-40.
3. BILEVICIUTE, I., LUNDEBERG, T., EKBLOM, A. & THEODORSSON, E. (1994a). Substance P-, neurokinin A-, calcilonin gene-related peptide-and neuropeptide Y-like immunoreactivity (-LI) in rat knee joint synovial fluid during acute monoarthritis is not correlated with concentrations of neuropeptides-LI in cerebrospinal fluid and plasma. Neurosci. Lett., 167, 145-148.
4. BILEVICIUTE, I., LUNDEBERG, T., EKBLOM, A. & THEODORSSON, E. (1994b). The effect of a single intraperitoneal dose of hrIL-1α on substance P-, neurokinin A-, calcitonin gene-related peptide-and neuropeptide Y-like immunoreactivity in cerebrospinal fluid, plasma and knee joint synovial fluid in the rat. Regul. Pept., 53, 71-76.
5. CAMERON, A.A., LEAH, J.D. & SNOW, P.J. (1988). The coexistence of neuropeptides in feline sensory neurons. Neuroscience, 27, 969-979.
6. CHIBA, T., YAMAGUCHI, A., YAMATANI, T., NAKAMURA, A., MORISHITA, T., INUI, T., FUKASE, M., NODA, T. & FUJITA, T. (1989). Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am. J. Physiol., 256, E331-E335.
7. COLLIN, E., FRECHILLA, D., POHL, M., BOURGOIN, S., LE BARS, D., HAMON, M. & CESSELIN, F. (1993). Opioid control the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo. Brain Res., 609, 211-222.
8. CRIDLAND, R.A. & HENRY, J.L. (1989). Intrathecal administration of CGRP in the rat attenuates a facilitation of the tail flick reflex induced by either substance P or noxious cutaneous stimulation. Neurosci. Lett., 102, 241-246.
9. CRUWYS, S.C., KIDD, B.L., MAPP, P.I., WALSH, D.A. & BLAKE, D.R. (1992). The effects of calcitonin gene-related peptide on formation of intra-articular oedema by inflammatory mediators. Br. J. Pharmacol., 107, 116-119.
10. 1 receptors in the maintenance of intra-articular plasma extravasation in chronic antigen-induced arthritis. Br. J. Pharmacol., 113, 940-944.
11. DENKO, C.W. & PETRICEVIC, M. (1978). Sympathetic or reflex footpad swelling due to crystal induced inflammation in the opposite foot. Inflammation, 3, 81-86.
12. DENNIS, T., FOURNIER, A., CADIEUX, A., POMERLEAU, F., JOLICOEUR, F.B., ST-PIERRE, S. & QUIRION, R. (1990). hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J. Pharmacol. Exp. Ther., 254, 123-128.
13. DONNER, J. & STEIN, C. (1992). Evidence for an increase in the release of CGRP from sensory nerves during inflammation. Ann. New York Acad. Sci., 657, 505-506.
14. DRAISCI, G., KAJANDER, K.C., DUBNER, R., BENNETT, G.J. & IADAROLA, M.J. (1991). Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation. Brain Res., 560, 186-192.
15. GARRY, M.G. & HARGREAVES, K.M. (1992). Enhanced release of immunoreactive CGRP and substance P from spinal dorsal horn slice occurs during carrageenan inflammation. Brain Res., 582, 139-142.
16. HANESCH, U., PFROMMER, U., GRUBB, B.D., HEPPELMANN, B. & SCHAIBLE, H.-G. (1993). The proportion of CGRP-immunoreactive and SP-mRNA containing dorsal root ganglion cells is increased by a unilateral inflammation of the ankle joint of the rat. Regul. Pept., 46, 202-203.
17. HÖKFELT, T., ARVIDSSON, U., CECCATELLI, S., CORTES, R., CULLHEIM, S., DAGERLIND, Å., JOHNSON, H., ORAZZO, C., PIEHL, F., PIERIBONE, V., SCHALLING, M., TERENIUS, L., ULFHAKE, B., VERGE, V.M., VILLAR, M., WIESENFELD-HALLIN, Z., XU, X.J. & ZHANG, X. (1992). Calcitonin gene-related peptide in the brain, spinal cord and some peripheral systems. Ann. New York Acad. Sci., 657, 119-133.
18. IADAROLA, M.J. & DRAISCI, G. (1988). Elevation of spinal cord dynorphin mRNA compared to dorsal root ganglion peptide mRNAs during peripheral inflammation. In The Arthritic Rat as a Model of Clinical Pain? ed. Besson, J.M. & Guilbaud, pp. 173-183. Amsterdam: Elsevier.
19. ISHIDA-YAMAMOTO, A., & TOHYAMA, M. (1989). Calcitonin gene-related peptide in the nervous tissue. Progr. Neurobiol. 33, 335-386.
20. IVERSEN, L.L. (1995). Neuropeptides: promise unfulfilled? Trends Neurosci., 18, 49-50.
21. KAWAMURA, M., KURAISHI, Y., MINAMI, M. & SATOH, M. (1989). Antinociceptive effect of intrathecally administered antiserum against calcitonin gene-related peptide on thermal and mechanical noxious stimuli in experimental hyperalgesic rats. Brain Res., 497, 199-203.
22. KURAISHI, Y., NANAYAMA, T., OHNO, H., MINAMI, M., SATOH, M. (1988). Antinociception induced in rats by intrathecal administration of antiserum against calcitonin gene-related peptide. Neurosci. Lett., 92, 325-329.
23. LE GREVES, L.P., NYBERG, F., TERENIUS, L. & HÖKFELT, T. (1985). Calcitonin gene-related peptide is a potent inhibitor of substance P degradation. Eur. J. Pharmacol., 115, 309-311.
24. LEMBECK, K. & DONNERER, J. (1985). Opioid control of the primary afferent substance P fiber. Eur. J. Pharmacol., 114, 241-246.
25. LEVINE, D.J., DARDICK, S.J., ROIZEN, M.F., BASBAUM, A.I. & SCIPIO, E. (1985). Reflex neurogenic inflammation. Contribution of the peripheral nervous system to spatially remote inflammatory responses that follow injury. J. Neurosci., 5, 1380-1386.
26. LUNDEBERG, T., MEISTER, B., BJÖRKSTRAND, E. & UVNÄSMOBERG, K. (1993). Oxytocin modulates the effects of galanin in carrageenan-induced hyperalgesia in rats. Brain Res., 608, 181-185.
27. MAGGI, C.A., CHIBA, T. & GIULIANI, S. (1991). Human χ-calcitonin gene-related peptide-(8-37) as an antagonist of exogenous and endogenous calcitonin gene-related peptide. Eur. J. Pharmacol., 192, 85-88.
28. MAO, J., COGHILL, R.C., KELLSTEIN, D.E., FRENK, H. & MAYER, D.J. (1992). Calcitonin gene-related peptide enhances substance P-induced behaviors via metabolic inhibition: in vivo evidence for a new mechanism of neuromodulation. Brain Res., 574, 157-163.
29. MAPP, P.I., TERENGI, G., WALSH, D.A., CHEN, S.T., CRUWYS, S.C., GARRETT, N., KIDD, B.L., POLAK, J.M. & BLAKE, D.R. (1993). Monoarthritis in the rat knee induces bilateral and time-dependent changes in substance P and calcitonin gene-related peptide immunoreactivity in the spinal cord. Neuroscience, 57, 1091-1096.
30. MAPP, P.I., WALSH, D.A., CRUWYS, S.C., KIDD, B.L., POLAK, J.M. & BLAKE, D.R. (1992). Localization of neutral endopeptidase to the human synovium. J. Rheumatol., 19, 1838-1844.
31. MAYER, E.A., RAYBOULD, H. & KOELBEL, C. (1988). Neuropeptides, inflammation, and motility. Dig. Dis. Sci., 33, 71S-77S.
32. MCNEILL, D.L., CHUNG, K., CARLTON, S.M. & COGGESHALL, R.E. (1988). Calcitonin gene-related peptide immunostained axons provide evidence for fine primary afferent fibers in the dorsal and dorsolateral funiculi of the rat spinal cord. J. Comp. Neurol., 272, 303-308.
33. NANAYAMA, T., KURAISHI, Y., OHNO, H. & SATOH, M. (1989). Capsaicin-induced release of calcitonin gene-related peptide from dorsal horn slice is enhanced in adjuvant arthritic rats. Neurosci. Res., 6, 569-572.
34. OKU, R., SATOH, M., FUJII, N., OTAKA, A., YAJIMA, H. & TAKAGI, H. (1987). Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats. Brain Res., 403, 350-354.
35. POHL, M., MAUBORGNE, A., BOURGOIN, S., BENOLIEL, J.J., HAMON, M. & CESSELIN, F. (1989). Neonatal capsaicin treatment abolishes the modulations by opioids of substance P release from rat spinal cord slices. Neurosci. Lett., 96, 102-107.
36. POYNER, D.R. (1992). Calcitonin gene-related peptide: multiple actions, multiple receptors. Pharmacol. Ther., 56, 23-51.
37. RYU, P.D., GERBE, G., MARASE, K.M. & MANDIC, M. (1988). Actions of calcitonin gene-related peptide on spinal dorsal horn neurones. Brain Res., 441, 357-361.
38. SATOH, M., KURAISHI, Y. & KAWAMURA, M. (1992). Effects of intrathecal antibodies to substance P, calcitonin gene-related peptide and galanin on repeated cold stress-induced hyperalgesia: comparison with carrageenan-induced hyperalgesia. Pain, 49, 273-278.
39. TAKAHASHI, O., SHIOSAKA, S., TRAUB, R.J. & RUDA, M.A. (1990). Ultrastructural demonstration of synaptic connections between calcitonin gene-related peptide immunoreactive axons and dynorphin A(1-8) immunoreactive dorsal horn neurons in a rat model of peripheral inflammation and hyperalgesia. Peptides, 11, 1233-1237.
40. THEODORSSON-NORHEIM, E., HEMSEN, A., BRODIN, E. & LUNDBERG J.M. (1990). Sample handling techniques when analyzing regulatory peptides. Life Sci., 41, 845-848.
41. TSCHOPP, F.A., HENKE, H., PETERMANN, J.B., TOBLER, P.H., JANZER, R., HÖKFELT, T., LUNDBERG, J.M., CUELLO, C. & FISHER, J.A. (1985). Calcitonin gene-related peptide and its binding sites in the human central nervous system and pituitary. Proc. Natl. Acad. Sci. U.S.A., 82, 248-252.
42. VINEGAR, R., SCHREIBER, W. & HUGO, R. (1969). Biphasic development of carrageenin edema in rats. J. Pharmacol. Exp. Ther., 166, 96-103.
43. WIESENFELT-HALLIN, Z., HÖKFELT, T., LUNDBERG, J.M., FORAMANN, W.G., REINECKE, M., TSCHOPP, F.A. & FISHER, J.A. (1984). Immunoreactive calcitonin gene-related peptide and substance P coexist in sensory neurones in the spinal cord and interact in spinal behavioural responses of the rat. Neurosci. Lett., 52, 199-204.
44. WILLIS, W.D. & COGGESHALL, R.E. (1991). Sensory Mechanisms of the Spinal Cord. (2nd edition) pp. 196-200. New York and London: Plenum Press.
45. WINTER, C.A., RISLEY, E.A. & NUSS, G.W. (1962). Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proc. Soc. Exp. Biol. Med., 111, 544-547.
46. WOOLF, C.J. & WIESENFELT-HALLIN, Z. (1986). Substance P and calcitonin gene-related peptide synergistically modulate the gain of the nociceptive flexor withdrawal reflex in the rat. Neurosci. Lett., 66, 226-230.
47. YAKSH, T.L. & MALMBERG, A.B. (1994). Central pharmacology of nociceptive transmission. In Textbook of Pain. (3rd edition) ed. Wall, P.D. & Melzack, R. pp. 165-190. Edinburgh: Churchill Livingstone.
48. YU, L.C., HANSSON, P. & LUNDEBERG, T. (1994). The calcitonin gene-related peptide antagonist CGRP8-37 increases the latency to withdrawal responses in rats. Brain Res., 653, 223-230.
49. YU, L.C., HANSSON, P. & LUNDEBERG, T. (1995). Opioid antagonists naloxone, β-funaltrexamine and naltrindole, but not norbinal-torphimine, reverse the increased hindpaw withdrawal latency in rats induced by intrathecal administration of the calcitonin gene-related peptide antagonist CGRP8-37. Brain Res., (in press).
50. 8-37 increases the latency to withdrawal responses bilaterally in rats with unilateral experimental mononeuropathy, an effect partly reversed by naloxone. Neurosci., (in press)